Ardian to sell majority stake in Novacap to Eurazeo, Merieux

Ardian, the Paris investment firm, agreed to sell a majority stake in Novacap to Eurazeo and Merieux Développement. Terms weren’t disclosed. Ardian said in a statement that it would retain a minority holding in Novacap. The deal is subject to regulatory clearances. With Ardian’s support in the past five years, Novacap, the Lyon, France, chemicals group, expanded internationally, making six acquisitions, Ardian said. Eurazeo is the Paris investment firm while Merieux, of Lyon, is a healthcare-focused fund with investments in diagnostics, medical devices and more.

DealsNorth AmericaUSBriefs